Sources | Names Used |
---|---|
CTRPv2 | doxorubicin:navitoclax (2:1 mol/mol) |
PharmacoGx | doxorubicin:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZAP70 | CTRPv2 | pan-cancer | AAC | 0.13 | 7e-05 |
mRNA | PXMP2 | CTRPv2 | pan-cancer | AAC | 0.13 | 7e-05 |
mRNA | BRD2 | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
mRNA | C17orf96 | CTRPv2 | pan-cancer | AAC | 0.13 | 7e-05 |
mRNA | PTPN1 | CTRPv2 | pan-cancer | AAC | -0.13 | 7e-05 |
mRNA | PCGF3 | CTRPv2 | pan-cancer | AAC | 0.13 | 7e-05 |
mRNA | STARD9 | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |
mRNA | DFFB | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |
mRNA | RBM5 | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
mRNA | FAM114A1 | CTRPv2 | pan-cancer | AAC | -0.16 | 7e-05 |